Lung cancer

December 15, 2021

Ongoing Trial: Clinical trial EA5182 is testing the addition of a drug to the most commonly used first treatment for patients with lung cancer that has spread

This study is exploring a new treatment option for patients with advanced (metastatic) non-small cell lung cancer that has the EGFR gene mutation